A framework for cost‐effectiveness analysis from clinical trial data
- 4 June 2001
- journal article
- economic evaluation
- Published by Wiley in Health Economics
- Vol. 10 (4) , 303-315
- https://doi.org/10.1002/hec.617
Abstract
We present a general Bayesian framework for cost-effectiveness analysis (CEA) from clinical trial data. This framework allows for very flexible modelling of both cost and efficacy related trial data. A common CEA technique is established for this wide class of models through linking mean efficacy and mean cost to the parameters of any given model. Examples are given in which efficacy may be measured as a continuous, binary, ordinal or time-to-event outcome, and in which costs are modelled as distributed normally, log-normally, as a mixture or non-parametrically. A case study is presented, illustrating the methodology and illuminating the role of prior information. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 18 references indexed in Scilit:
- Bayesian cost‐effectiveness analysis from clinical trial dataStatistics in Medicine, 2001
- Low doses vs. high doses of the angiotensin converting‐enzyme inhibitor lisinopril in chronic heart failure: a cost‐effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) studyEuropean Journal of Heart Failure, 2000
- Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.PharmacoEconomics, 2000
- Cost Effectiveness of Helicobacter pylori Eradication Therapies in Patients with Duodenal UlcerPharmacoEconomics, 1999
- Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma II: Study MethodologiesPharmacoEconomics, 1999
- Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40BMJ, 1998
- Confidence intervals for cost-effectiveness ratios: An application of Fieller's theoremHealth Economics, 1996
- A 1-Year Comparison of Turbuhaler vs Pressurized Metered-Dose Inhaler in Asthmatic PatientsChest, 1996
- Confidence intervals for cost/effectiveness ratiosHealth Economics, 1995
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994